BRCA1 Basal-like Breast Cancers Originate from Luminal Epithelial Progenitors and Not from Basal Stem Cells
Gemma Molyneux(Institute of Cancer Research), Matthew J. Smalley(Cardiff University), Anita Grigoriadis(London Cancer), Rachael Natrajan(Institute of Cancer Research), Afshan McCarthy(Institute of Cancer Research), Alan Mackay(Institute of Cancer Research), Jorge S. Reis‐Filho(AstraZeneca (France)), Howard Kendrick(Institute of Cancer Research), Andrew Tutt(Institute of Cancer Research), Felipe C. Geyer(Institute of Cancer Research), Alan Ashworth(University of California, San Francisco), Fiona‐Ann Magnay(Institute of Cancer Research)
Cited by 814
Related Papers
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
|The Lancet|2010|2.3k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k